Akira Yokota

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Journal: Nature medicine

Published: May 05, 2026

Nationwide surveillance of antibacterial susceptibility patterns of bacterial pathogens isolated from otorhinolaryngological infectious diseases in Japan.

Nationwide surveillance of antibacterial susceptibility patterns of bacterial pathogens isolated from otorhinolaryngological infectious diseases in Japan.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: February 24, 2026

Hydrolyzed Milk-Derived Peptides Promote Erythropoietin Pathways and Hematologic Recovery: A Cross-Species Analysis.

Hydrolyzed Milk-Derived Peptides Promote Erythropoietin Pathways and Hematologic Recovery: A Cross-Species Analysis.

Journal: Molecules (Basel, Switzerland)

Published: November 12, 2025

Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Journal: Nature medicine

Published: October 24, 2025

Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation.

Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: September 05, 2025

A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasm.

A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasm.

Journal: International journal of hematology

Published: July 27, 2025

Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma.

Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma.

Journal: Hematological oncology

Published: February 10, 2025

Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351.

Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351.

Journal: International journal of hematology

Published: December 16, 2024

Multiple myeloma presenting with retroperitoneal fibrosis and elevated IgG4.

Multiple myeloma presenting with retroperitoneal fibrosis and elevated IgG4.

Journal: International journal of hematology

Published: December 10, 2024

Dictyobacter halimunensis sp. nov., a new member of the phylum Chloroflexota, from forest soil in a geothermal area.

Dictyobacter halimunensis sp. nov., a new member of the phylum Chloroflexota, from forest soil in a geothermal area.

Journal: International journal of systematic and evolutionary microbiology

Published: December 04, 2024

A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.

A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.

Journal: International journal of hematology

Published: May 09, 2024

Correction: Vulcanimicrobium alpinus gen. nov. sp. nov., the first cultivated representative of the candidate phylum "Eremiobacterota", is a metabolically versatile aerobic anoxygenic phototroph.

Correction: Vulcanimicrobium alpinus gen. nov. sp. nov., the first cultivated representative of the candidate phylum "Eremiobacterota", is a metabolically versatile aerobic anoxygenic phototroph.

Journal: ISME communications

Published: October 17, 2023

Showing 1-12 of 70

Last Updated: 09/26/2026